COVID-19 Stress Drives Anxiety-Reducing Supplement Sales Up 79% In US Since 2018
Sales for anxiety/stress relief dietary supplements in 2020 grew 79% from 2018, eclipsing growth of 22% for general herbal supplements during the same comparison period. Stress-relief supplements including St. John’s wart, ashwagandha and cannabinoids continue to grow in popularity.
You may also be interested in...
FDA warns 10 businesses they’re marketing unapproved and misbranded drugs by making claims for supplements to treat depression. Supplement also found with one of, if not the most common violations in the US supplement market: it contained an undisclosed ED drug.
FDA asks two Mexican manufacturers for batch and supplier data on the products found to contain mostly methanol instead of ethanol. Its The FDA’s recall records still are frequently updated with announcements of additional recalls of OTC sanitizers due to the presence of methanol.
Anytime COVID Test marketed home-use test without FDA approval or EUA and promoted it with an FDA logo and a “clinical trial number.” Warning letter says “your presentation conveys the misimpression that the product has been approved, cleared, authorized, endorsed or otherwise evaluated by FDA.”